BA
PMC

Boston Advisors’s PharMerica Corporation PMC Stock Holding History

Boston Advisors’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,180
Closed -$503K – 692
2017
Q2 		$503K Sell
19,180
-1,285
-6% -$31.6K 0.01% 495
2017
Q1 		$479K Sell
20,465
-5,465
-21% -$135K 0.01% 479
2016
Q4 		$652K Buy
25,930
+4,445
+21% +$112K 0.02% 424
2016
Q3 		$603K Buy
21,485
+1,500
+8% +$38.5K 0.01% 462
2016
Q2 		$493K Buy
19,985
+105
+0.5% +$2.6K 0.01% 482
2016
Q1 		$440K Sell
19,880
-190
-0.9% -$5.06K 0.01% 488
2015
Q4 		$702K Buy
20,070
+9,120
+83% +$286K 0.02% 385
2015
Q3 		$312K Buy
+10,950
New +$368K 0.01% 657

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Boston Advisors's PMC Position: Q3 2017 in Review

Boston Advisors sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 19,180 shares — an estimated $503K sold.

Boston Advisors first reported a position in PMC in Q3 2015 and held it in 8 quarters. The position peaked at $702K in Q4 2015. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Boston Advisors reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Boston Advisors sold 19,180 PharMerica Corporation shares in Q3 2017, an estimated $503K.
  • Boston Advisors first reported a position in PharMerica Corporation in Q3 2015 and held it in 8 quarters.
  • Boston Advisors's PharMerica Corporation position peaked at $702K in Q4 2015.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Boston Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.